Sepúlveda B
Rev Infect Dis. 1982 Nov-Dec;4(6):1247-53.
Invasive amebiasis caused by Entamoeba histolytica, and particularly amebic liver abscess, is a major public health problem in Mexico and some other countries because of the high incidence and mortality of this disease. This paper first discusses the pathogenic effect of E. histolytica and the defensive response of the host and then reports studies concerning the experimental induction of protective immunity to amebic infection. The pathogenic effect of E. histolytica is probably initiated by a lectin-mediated adhesion of trophozoites to target cells; the adhesion is followed by cytopathic activity and phagocytosis by the ameba. The defensive response is characterized by humoral and cellular immune reactions. Humoral immunity manifests itself by specific circulating antibodies useful in the diagnosis and seroepidemiology of amebiasis. Cellular immunity is shown by several characteristic reactions. Experimental induction of immunoprophylaxis with E. histolytica antigens represents the first stage in the development of a vaccine against E. histolytica for use in humans.
由溶组织内阿米巴引起的侵袭性阿米巴病,尤其是阿米巴肝脓肿,在墨西哥和其他一些国家是一个重大的公共卫生问题,因为这种疾病的发病率和死亡率很高。本文首先讨论溶组织内阿米巴的致病作用和宿主的防御反应,然后报告有关实验诱导对阿米巴感染的保护性免疫的研究。溶组织内阿米巴的致病作用可能始于滋养体通过凝集素介导与靶细胞的粘附;随后是细胞病变活性和阿米巴的吞噬作用。防御反应的特征是体液和细胞免疫反应。体液免疫通过对阿米巴病诊断和血清流行病学有用的特异性循环抗体表现出来。细胞免疫通过几种特征性反应表现出来。用溶组织内阿米巴抗原进行免疫预防的实验诱导是开发用于人类的抗溶组织内阿米巴疫苗的第一阶段。